Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment

Hunan Province Tumor Hospital

Status: Completed

Conditions: Non Small Cell Lung Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT05205226

SPLENDOR

Details and patient eligibility

About

This study aimed to confirmed that local radiotherapy for residual lesions can significantly prolong the efficacy of chemotherapy combined with immunotherapy in the initial treatment of advanced non-small cell lung cancer.

Enrollment: 636 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ≥18，Advanced Non-small Cell Lung Cancer Confirmed by Histopathology Patients received platinum-based chemotherapy combined with immunotherapy

Exclusion criteria

• EGFR/ALK/ROS1 driver gene mutation
• Chemotherapy only
• Concurrent radio-chemotherapy
• Surgery
• Single-agent immunotherapy
• No treatment information available